In the last year, a renewed focus on climate change is putting clean energy stocks in focus. This group of stocks includes companies who are committed to doing no harm to the environment. But did you know there’s a sector that also focuses on repairing the damage that’s already been done?
That’s the mission of green tech. Green tech refers to companies that utilize technology that is explicitly designed to protect the environment or repairing existing change. That includes what you might consider the “usual suspects” of wind and solar. But it goes into other areas such as organic food and upcycling.
On this week’s episode of the MarketBeat Podcast, Kate Stalter sits down with investor Brendan Coffey to take a deeper dive into this fast-growing category. And Coffey explains why many of these stocks are poised to break out of a dormant period.
Some of the topics the podcast will cover include:
- How investing in green tech is similar (and different) from environmental, social, and governance (ESG) investing?
- What are some of the long-term opportunities for green tech?
- What index Coffey uses to track green tech stocks?
And you’ll hear Coffey explain why the decision to invest in green tech is not an alternative to growth stocks, but a shift to where the growth is going. With that said, you’ll hear about one semiconductor company that makes the list of stocks he’s buying now.
That’s the kind of insight you get from the MarketBeat Podcast. This weekly 30-minute podcast is an ideal companion on your daily walk or when you’re doing errands. Your host is Kate Stalter. Stalter brings 20 years of experience in various areas of financial services to help clarify what’s really going on in the market.
New episodes of the MarketBeat Podcast will be released every week and subscribing to the podcast is completely free. Simply subscribe to the MarketBeat Podcast from wherever you get your podcasts.
Apple Podcasts - Spotify - iHeart - Overcast - Amazon
Let’s all become smarter investors together. Subscribe to The MarketBeat Podcast today.7 Great Biotech Stocks to Buy in Expectations of Better Days Ahead
The biotechnology (biotech) sector was one of the best performing sectors in 2020. Many companies saw their stock prices rise as the race was on for a Covid-19 vaccine.
However, many of these companies were pre-revenue companies. Or they were companies that only had one or two in-market products or therapies. And as the calendar turned to 2021, investors took notice. And what went up quickly went down. And in the case of the biotech sector, it came down hard.
One way to tell is to look at biotech ETFs. One of the most popular ETFs, the VanEck Vectors Biotech ETF (NYSEARCA:BBH) is down more than 15%. So you can imagine what it’s been like for many individual biotech stocks. If you’re a buy-and-hold investor, you’re licking some wounds right about now.
But investors who knew what companies to buy have done well. And many of those names will continue to lead the biotech sector in 2022. In this special presentation, we give investors seven biotech stocks that represent different aspects of this diverse sector. We’re confident there’s something for investors of all risk tolerances. View the "7 Great Biotech Stocks to Buy in Expectations of Better Days Ahead"